Mycobacterium Abscessus Infection
📧 Sign up to get email alerts when something new happens for Mycobacterium Abscessus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial [Phase 2]
This clinical trial update outlines the Phase 2 FORMaT adaptive platform trial evaluating a novel combination treatment (Arm D) versus stand…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection [Phase 1]
A Phase 1 clinical trial update for bacteriophage therapy targeting chronic pulmonary infection caused by Mycobacterium abscessus; the study…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Epetraborole in Patients With Mycobacterium Abscessus Lung Disease [Phase 2]
Epetraborole is being studied in a Phase 2 trial for Mycobacterium abscessus infection, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease [Phase 2]
This is a Phase 2 clinical study evaluating the early bactericidal activity of contezolid against Mycobacterium abscessus infection, current…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at Home
This clinical trial update describes a case-control study in cystic fibrosis households to assess exposure risk to environmental reservoirs …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection [Phase 1]
Phase 1 clinical trial update indicates bacteriophage therapy for Mycobacterium abscessus pulmonary infection is enrolling by invitation for…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex [Phase 2]
A Phase 2 trial is evaluating delpazolid as add-on therapy for refractory Mycobacterium abscessus complex infections; the study is currently…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) [Phase 2]
A Phase 2 trial comparing oral omadacycline to placebo in adults with nontuberculous mycobacterial pulmonary disease caused by the Mycobacte…
-
CLINICAL_TRIALS trial_result · 2019-07-09Clinical Trial Update: Inhaled Nitric Oxide for Patients With MABSC [Phase 2]
Phase 2 trial update on inhaled nitric oxide for patients with Mycobacterium abscessus infection has completed.